M

MedinCell
MEDCL

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
€494.28M
EV
€524.63M
Shares Outstanding
33.32M
Beta
1.27

Wall Street View

Analyst Rating
BUY
Analyst Target Price
€22.40
P/E 2025E
-
P/Revenue 2025E
24.14x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About MedinCell S.A.

gainify

M

MedinCell S.A.

MEDCL

MedinCell S.A., a pharmaceutical company, develops long acting injectables in various therapeutic areas in France. It develops solutions based on BEPO, a long-acting injectable technology; and offers UZEDY (mdc-IRM) for the treatment of schizophrenia in adults. The co...

Sector

Healthcare

Industry

Biotechnology

CEO

Douat, Christophe

Employees

131

IPO Date

2018-10-08

Headquarters

3 rue des FrEres LumiEre, Jacou, Languedoc-Roussillon, 34830, France

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved